Skip to main content
. 2005 Jun 7;11(21):3182–3188. doi: 10.3748/wjg.v11.i21.3182

Figure 1.

Figure 1

Supranuclear CDX2 immunostaining in non-neoplastic gastric mucosa (A), signet-ring cell carcinoma (B) and tubular adenocarcinoma (C) of the stomach. MUC2 expression in non-neoplastic gastric tissue (D), signet-ring cell (E) and tubular adenocarcinoma (F).